SE9401480L - En ny 78-resters polypeptid (NK-lysin) och dess användning - Google Patents

En ny 78-resters polypeptid (NK-lysin) och dess användning

Info

Publication number
SE9401480L
SE9401480L SE9401480A SE9401480A SE9401480L SE 9401480 L SE9401480 L SE 9401480L SE 9401480 A SE9401480 A SE 9401480A SE 9401480 A SE9401480 A SE 9401480A SE 9401480 L SE9401480 L SE 9401480L
Authority
SE
Sweden
Prior art keywords
pct
polypeptide
sec
date
lysine
Prior art date
Application number
SE9401480A
Other languages
Unknown language ( )
English (en)
Other versions
SE502670C2 (sv
SE9401480D0 (sv
Inventor
Hans Joernvall
Hans G Boman
Viktor Mutt
Mats Andersson
Original Assignee
Mats Andersson
Hans Joernvall
Hans G Boman
Viktor Mutt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mats Andersson, Hans Joernvall, Hans G Boman, Viktor Mutt filed Critical Mats Andersson
Priority to SE9401480A priority Critical patent/SE502670C2/sv
Publication of SE9401480D0 publication Critical patent/SE9401480D0/sv
Priority to EP95918245A priority patent/EP0753012A1/en
Priority to PCT/SE1995/000475 priority patent/WO1995029937A1/en
Priority to US08/732,228 priority patent/US5981469A/en
Priority to JP7528154A priority patent/JPH09512546A/ja
Priority to AU24236/95A priority patent/AU2423695A/en
Publication of SE9401480L publication Critical patent/SE9401480L/sv
Publication of SE502670C2 publication Critical patent/SE502670C2/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SE9401480A 1994-04-29 1994-04-29 En ny 78-resters polypeptid (NK-lysin) och dess användning SE502670C2 (sv)

Priority Applications (6)

Application Number Priority Date Filing Date Title
SE9401480A SE502670C2 (sv) 1994-04-29 1994-04-29 En ny 78-resters polypeptid (NK-lysin) och dess användning
EP95918245A EP0753012A1 (en) 1994-04-29 1995-04-28 A new 78 residue polypeptide (nk-lysine) and its use
PCT/SE1995/000475 WO1995029937A1 (en) 1994-04-29 1995-04-28 A new 78 residue polypeptide (nk-lysine) and its use
US08/732,228 US5981469A (en) 1994-04-29 1995-04-28 78 residue polypeptide (NK-lysine) and its use
JP7528154A JPH09512546A (ja) 1994-04-29 1995-04-28 新規な７８残基ポリペプチド（ｎｋ−リジン）およびその使用
AU24236/95A AU2423695A (en) 1994-04-29 1995-04-28 A new 78 residue polypeptide (nk-lysine) and its use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9401480A SE502670C2 (sv) 1994-04-29 1994-04-29 En ny 78-resters polypeptid (NK-lysin) och dess användning

Publications (3)

Publication Number Publication Date
SE9401480D0 SE9401480D0 (sv) 1994-04-29
SE9401480L true SE9401480L (sv) 1995-10-30
SE502670C2 SE502670C2 (sv) 1995-12-04

Family

ID=20393838

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9401480A SE502670C2 (sv) 1994-04-29 1994-04-29 En ny 78-resters polypeptid (NK-lysin) och dess användning

Country Status (6)

Country Link
US (1) US5981469A (sv)
EP (1) EP0753012A1 (sv)
JP (1) JPH09512546A (sv)
AU (1) AU2423695A (sv)
SE (1) SE502670C2 (sv)
WO (1) WO1995029937A1 (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6485928B2 (en) * 1997-11-04 2002-11-26 The Board Of Trustees Of The Leland Stanford Junior University Use of granulysin as an antimicrobial agent
AU2005100473B4 (en) * 2005-06-03 2005-07-14 Rheem Australia Pty Limited Water heater

Also Published As

Publication number Publication date
US5981469A (en) 1999-11-09
JPH09512546A (ja) 1997-12-16
AU2423695A (en) 1995-11-29
EP0753012A1 (en) 1997-01-15
SE502670C2 (sv) 1995-12-04
WO1995029937A1 (en) 1995-11-09
SE9401480D0 (sv) 1994-04-29

Similar Documents

Publication Publication Date Title
MX9705954A (es) Formulaciones y metodos para reducir irritacion de la piel.
NO952321D0 (no) Polypeptid, samt anti-HIV-preparat fremstilt fra dette
MX9504332A (es) Derivados de amino(tio)eter y procedimiento para su preparacion.
IL112111A0 (en) Peptide derivatives and pharmaceutical compositions containing them
BG60102B2 (bg) Метод за получаване на 5-флуор-2(((4-циклопропил- метокси-2-пиридинил)метил)тионил)-1н-бензимидазол
MX9705710A (es) Compuestos con propiedades de liberacion de la hormona del crecimiento.
AU5956398A (en) Remedies for lymphocytic tumors
MY135057A (en) Dolastatin 15 derivatives
SE9101838D0 (sv) Novel peptides and their use
DE68926679D1 (de) Physiologisch aktives polypeptid, rekombinantes plasmid, rekombinante mikrobielle zellen, medizinisches präparat sowie verfahren zur gewinnung des gereinigten polypeptids
AU4363199A (en) Use of hmg proteins for the preparation of medicaments having cytotoxic activity
SE9604593D0 (sv) Antimicrobially active polypeptides
LTIP610A (en) Inhibitors of cells proliferation, pharmaceutical composition and method for preparation of compounds
SE9402880D0 (sv) New peptide derivatives
SE9401480L (sv) En ny 78-resters polypeptid (NK-lysin) och dess användning
ATE3416T1 (de) Pharmakologisch aktive peptide und diese enthaltende arzneimittel.
SE9403055D0 (sv) A new human peptide antibiotic (FALL-39) and its use
BG103905A (en) New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine
EP1074264A4 (en) NEOVASCULARIZATION INHIBITORS
DE69619530D1 (de) Zyklische somatostatinanaloge mit wachstumhormon inhibierender aktivität
NZ503027A (en) Use of rifamycin derivative for treating mastitis in a domestic animal
GB9513750D0 (en) Use of allylamines
FI961505A0 (sv) Nya peptidföreningar, som är terapeutiskt aktiva i blodkoaguleringssystem, förfarande för deras framställning och farmaceutiska kompositioner, som innehåller dem
KR950704358A (ko) 카텝신 l 특이적 저해 폴리펩티드
MX9800686A (es) Nueva proteina hmw humana mp52s.

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 9401480-0

Format of ref document f/p: F